Innate Pharma News

Innate Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Caisse des dépôts et consignations(9.0%),Bpifrance Participations S.A.(8.0%), etc.

Dec 7, 2022 00:52

Innate Pharma | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Caisse des dépôts et consignations(10.0%),Bpifrance Participations S.A.(8.0%), etc.

Oct 22, 2022 00:58

Innate Pharma | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities

Feb 13, 2021 03:35

Innate Pharma | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Feb 3, 2020 20:00

Innate Pharma | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities

Oct 26, 2019 02:36

Innate Pharma | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

Oct 24, 2019 04:08

Innate Pharma | D: Filing D

Feb 1, 2014 01:47